Search Results Search Sort by RelevanceMost Recent Case and Commentary Oct 2021 When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Michael J. Young, MD, MPhil, Robert W. Regenhardt, MD, PhD, Leonard L. Sokol, MD, and Thabele M. Leslie-Mazwi, MD For some patients whose survival is extended by disease-modifying interventions, little guidance about clinical and ethical complexities exist. AMA J Ethics. 2021;23(10):E783-793. doi: 10.1001/amajethics.2021.783. Case and Commentary Jan 2016 Could Good Care Mean Withholding Information from Patients? Benjamin D. Long and Andrew G. Shuman, MD A physician may withhold information from a patient if he believes that he is acting in accordance with the patient’s wishes and best interests. AMA J Ethics. 2016;18(1):6-11. doi: 10.1001/journalofethics.2017.18.1.ecas1-1601. Case and Commentary Oct 2020 What Should Physicians Consider About American Indian/Alaska Native Women’s Reproductive Freedom? Felina Cordova-Marks, DrPH, MPH, Nikki Fennimore, MD, Amanda Bruegl, MD, and Jennifer Erdrich, MD, MPH For patients historically stripped of control over their reproductive health, consideration of past violations and transparent discussion are key. AMA J Ethics. 2020;22(10):E845-850. doi: 10.1001/amajethics.2020.845. Case and Commentary Nov 2017 What Should Leaders Do When Inefficiency Is Perceived as a Cost of Inclusivity in Strategic Planning Processes in Health Care? Aveena Kochar, MD and Alia Chisty, MS, MD Commentary by Aveena Kochar, MD, and Alia Chisty, MS, MD Co-creative teams can overcome conflict by drawing on quality improvement principles. AMA J Ethics. 2017;19(11):1081-1087. doi: 10.1001/journalofethics.2017.19.11.ecas2-1711. Case and Commentary Aug 2020 What Does Good Pharmacist-Physician Pain Management Collaboration Look Like? Kyle Bryan, PharmD and Thomas E. Menighan, MBA Both physicians and pharmacists have responsibilities to ensure that opioids are prescribed and dispensed for legitimate medical purposes and to meet legal requirements. AMA J Ethics. 2020;22(8):E675-680. doi: 10.1001/amajethics.2020.675. Case and Commentary Apr 2019 How Should Physicians Help Patients Understand Unknowns of Nanoparticle-Based Medicines? Nancy M. P. King, JD and Christine E. Bishop, MD, MA When an unproven intervention is a nanodrug, a physician’s role is especially difficult due to possibilities of unprecedented harms. AMA J Ethics. 2019;21(4):E324-331. doi: 10.1001/amajethics.2019.324. Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317. Case and Commentary Oct 2019 How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making? Alexander J. Hjelmaas, MD and Christian J. Vercler, MD, MA Regulations’ negative influence on patient-physician relationships can be mitigated by innovation in decision science. AMA J Ethics. 2019;21(10):E838-843. doi: 10.1001/amajethics.2019.838. Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021. Case and Commentary Jun 2018 Is It Ethical to Treat Pain Differently in Children and Adults with Burns? Sharmila Dissanaike, MD Pain management of adult and pediatric burn patients should be individualized and include nonpharmacological treatment. AMA J Ethics. 2018;20(6):531-536. doi: 10.1001/journalofethics.2018.20.6.cscm1-1806. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Oct 2021 When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative? Michael J. Young, MD, MPhil, Robert W. Regenhardt, MD, PhD, Leonard L. Sokol, MD, and Thabele M. Leslie-Mazwi, MD For some patients whose survival is extended by disease-modifying interventions, little guidance about clinical and ethical complexities exist. AMA J Ethics. 2021;23(10):E783-793. doi: 10.1001/amajethics.2021.783.
Case and Commentary Jan 2016 Could Good Care Mean Withholding Information from Patients? Benjamin D. Long and Andrew G. Shuman, MD A physician may withhold information from a patient if he believes that he is acting in accordance with the patient’s wishes and best interests. AMA J Ethics. 2016;18(1):6-11. doi: 10.1001/journalofethics.2017.18.1.ecas1-1601.
Case and Commentary Oct 2020 What Should Physicians Consider About American Indian/Alaska Native Women’s Reproductive Freedom? Felina Cordova-Marks, DrPH, MPH, Nikki Fennimore, MD, Amanda Bruegl, MD, and Jennifer Erdrich, MD, MPH For patients historically stripped of control over their reproductive health, consideration of past violations and transparent discussion are key. AMA J Ethics. 2020;22(10):E845-850. doi: 10.1001/amajethics.2020.845.
Case and Commentary Nov 2017 What Should Leaders Do When Inefficiency Is Perceived as a Cost of Inclusivity in Strategic Planning Processes in Health Care? Aveena Kochar, MD and Alia Chisty, MS, MD Commentary by Aveena Kochar, MD, and Alia Chisty, MS, MD Co-creative teams can overcome conflict by drawing on quality improvement principles. AMA J Ethics. 2017;19(11):1081-1087. doi: 10.1001/journalofethics.2017.19.11.ecas2-1711.
Case and Commentary Aug 2020 What Does Good Pharmacist-Physician Pain Management Collaboration Look Like? Kyle Bryan, PharmD and Thomas E. Menighan, MBA Both physicians and pharmacists have responsibilities to ensure that opioids are prescribed and dispensed for legitimate medical purposes and to meet legal requirements. AMA J Ethics. 2020;22(8):E675-680. doi: 10.1001/amajethics.2020.675.
Case and Commentary Apr 2019 How Should Physicians Help Patients Understand Unknowns of Nanoparticle-Based Medicines? Nancy M. P. King, JD and Christine E. Bishop, MD, MA When an unproven intervention is a nanodrug, a physician’s role is especially difficult due to possibilities of unprecedented harms. AMA J Ethics. 2019;21(4):E324-331. doi: 10.1001/amajethics.2019.324.
Case and Commentary Apr 2019 Should a Psychiatrist Prescribe a Nanodrug to Help Parents Monitor a Teen’s Adherence? Constance E. George, MD, MA Ethical stakes include a psychiatrist’s care management responsibilities and burdens borne by family members over the course of the patient’s care. AMA J Ethics. 2019;21(4):E317-323. doi: 10.1001/amajethics.2019.317.
Case and Commentary Oct 2019 How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making? Alexander J. Hjelmaas, MD and Christian J. Vercler, MD, MA Regulations’ negative influence on patient-physician relationships can be mitigated by innovation in decision science. AMA J Ethics. 2019;21(10):E838-843. doi: 10.1001/amajethics.2019.838.
Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021.
Case and Commentary Jun 2018 Is It Ethical to Treat Pain Differently in Children and Adults with Burns? Sharmila Dissanaike, MD Pain management of adult and pediatric burn patients should be individualized and include nonpharmacological treatment. AMA J Ethics. 2018;20(6):531-536. doi: 10.1001/journalofethics.2018.20.6.cscm1-1806.